期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Corrigendum to“Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function”[Liver Res.5(2021)171-180]
1
作者 Mohammad Mehdi Ommati Hamidreza Mohammadi +7 位作者 Khadijeh Mousavi Negar Azarpira omid farshad Reyhaneh Dehghani Asma Najibi Sedigheh Kamran Hossein Niknahad Reza Heidari 《Liver Research》 2025年第4期365-365,共1页
The authors regret that an error has been identified in Fig.5 of this original article.Specifically,the representative image of BDL group was incorrectly selected during figure assembly.The corrected version of Fig.5 ... The authors regret that an error has been identified in Fig.5 of this original article.Specifically,the representative image of BDL group was incorrectly selected during figure assembly.The corrected version of Fig.5 is shown below.This correction does not affect the overall results,interpretations,and conclusions of the study. 展开更多
关键词 liver research representative image oxidative stress bdl group correction cholestasis associated nephropathy METFORMIN mitochondrial function
原文传递
Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function 被引量:3
2
作者 Mohammad Mehdi Ommati Hamidreza Mohammadi +7 位作者 Khadijeh Mousavi Negar Azarpira omid farshad Reyhaneh Dehghani Asma Najibi Sedigheh Kamran Hossein Niknahad Reza Heidari 《Liver Research》 CSCD 2021年第3期171-180,共10页
Background and aim:Cholestasis-associated renal injury or cholemic nephropathy(CN)is a serious clinical problem.Previous studies mentioned that oxidative stress and mitochondrial impairment play a role in CN.There is ... Background and aim:Cholestasis-associated renal injury or cholemic nephropathy(CN)is a serious clinical problem.Previous studies mentioned that oxidative stress and mitochondrial impairment play a role in CN.There is no specific pharmacological intervention for CN.Metformin is an anti-diabetic drug administered for decades.On the other hand,novel pharmacological properties have emerged for this drug.The effect of metformin on oxidative stress parameters has been well-recognized in different experimental models.It has also been found that metformin positively affected mitochondrial function.The current study aimed to evaluate the effects of metformin in an animal model of CN.Methods:Rats underwent bile duct ligation(BDL)and were treated with metformin(250 and 500 mg/kg)for 14 consecutive days.Two weeks after the BDL operations,urine,serum,and kidney samples were collected and analyzed.Results:Markers of oxidative stress,including reactive oxygen species(ROS)formation,lipid peroxida-tion,protein carbonylation,depleted antioxidant capacity,and decreased glutathione(GSH)levels were detected in BDL animals.Moreover,mitochondrial indices,including adenosine triphosphate(ATP)level,dehydrogenase activity,mitochondrial membrane potential,and mitochondrial permeability,were impaired in the kidney of cholestatic rats.Renal histopathological alterations in cholestatic animals included tubular degeneration and interstitial inflammation,cast formation,and fibrosis.It was found that metformin significantly alleviated oxidative stress and improved mitochondrial indices in the kidney of cholestatic rats.Tissue histopathological alterations were also mitigated in metformin-treated groups.Conclusions:Metformin could be a candidate for managing CN.The nephroprotective role of metformin is primarily associated with its effects on oxidative stress parameters and mitochondrial function. 展开更多
关键词 METFORMIN Bile acids CHOLESTASIS CIRRHOSIS Oxidative stress Mitochondrial function Energy crisis Cholemic nephropathy(CN) Renal failure
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部